Group Medical Visits (GMVs) in primary care: an RCT of group-based versus individual appointments to reduce HbA1c in older people

Karim M Khan, Adriaan Windt, Jennifer C Davis, Martin Dawes, Teresa Liu-Ambrose, Ken Madden, Carlo A Marra, Laura Housden, Christiane Hoppmann, David J Adams, Karim M Khan, Adriaan Windt, Jennifer C Davis, Martin Dawes, Teresa Liu-Ambrose, Ken Madden, Carlo A Marra, Laura Housden, Christiane Hoppmann, David J Adams

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) affects more than 1.1 million Canadians aged ≥65 years. Group Medical Visits are an emerging health service delivery method. Recent systematic reviews show that they can significantly reduce glycated haemoglobin (HbA1c) levels, but Group Visits have not been evaluated within primary care. We intend to determine the clinical effectiveness, quality of life and economic implications of Group Medical Visits within a primary care setting for older people with T2DM.

Methods and analysis: A 2-year proof-of-concept, single-blinded (measurement team) randomised control trial to test the efficacy of Group Medical Visits in an urban Canadian primary care setting. Participants ≥65 years old with T2DM (N=128) will be equally randomised to either eight groups of eight patients each (Group Medical Visits; Intervention) or to Individual visits (Standard Care; Controls). Those administering cointerventions are not blinded to group assignment. Our sample size is based on estimates of variance (±1.4% for HbA1c) and effect size (0.9/1.4=0.6) from the literature and from our own preliminary data. Forty participants per group will provide a β likelihood of 0.80, assuming an α of 0.05. A conservative estimation of an effect size of 0.7/1.4 changes the N in the power calculation to 59 per group. Hence, we aim to enrol 64 participants in each study arm. We will use intention-to-treat analysis and compare mean HbA1c (% glycosylated HbA1c) (primary outcome) of Intervention/Control participants at 12 months, 24 months and 1 year postintervention on selected clinical, patient-rated and economic measures.

Trial registration number: NCT02002143.

Keywords: PRIMARY CARE; PUBLIC HEALTH.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure1
Figure1
CONSORT—Group Medical Visits (GMVs) in primary care: protocol for an randomised controlled trial of group-based versus individual appointments to reduce glycated haemoglobin in older people.

References

    1. Booth G, Cheng AYY, Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013; 37(Suppl 1):S4–7.
    1. Public Health Agency of Canada. Diabetes in Canada: facts and figures from a public health perspective 2011. Ottawa: Government of Canada, 2011.
    1. Lysy Z, Booth G, Shah B et al. . The impact of income on the incidence of diabetes: a population based study. Diabetes Res Clin Pract 2013;99:372–9. 10.1016/j.diabres.2012.12.005
    1. Dyck R, Karunanayake C, Pahwa P et al. . Prevalence, risk factors and co-morbidities of diabetes among adults in rural Saskatchewan: the influence of farm residence and agriculture-related exposures. BMC Public Health 2013;13:7 10.1186/1471-2458-13-7
    1. Cauch-Dudek K, Victor JC, Sigmond M et al. . Disparities in attendance at diabetes self-management education programs after diagnosis in Ontario, Canada: a cohort study. BMC Public Health 2013;13:85 10.1186/1471-2458-13-85
    1. Meneilly G. Diabetes in the elderly. In: JE M, ed. Medical clinics of North America—geriatric medicine. Philadelphia, PA: Elsevier Saunders, 2006:909–23.
    1. Doucet G, Beatty M. The cost of diabetes in Canada: the economic tsunami. Can J Diabetes 2010;34:27–9. 10.1016/S1499-2671(10)41005-9
    1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033–46. 10.2337/dc12-2625
    1. Caro J, Getsios D, Caro I et al. . Economic evaluation of therapeutic interventions to prevent type 2 diabetes in Canada. Diabet Med 2004;21:1229–36. 10.1111/j.1464-5491.2004.01330.x
    1. Moffatt E, Shack L, Petz G et al. . The cost of obesity and overweight in 2005: a case study of Alberta Canada. Can J Public Health 2011;102:144–8.
    1. Knowler WC. Prevention of type 2 diabetes: comment on Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels. Arch Intern Med 2011;171:1361–2. 10.1001/archinternmed.2011.367
    1. Steinsbekk A, Rygg L, Lisulo M et al. . Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with metaanalysis. BMC Health Serv Res 2012;12:213 10.1186/1472-6963-12-213
    1. Umpierre D, Ribeiro P, Schaan B et al. . Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia 2013;56:242–51. 10.1007/s00125-012-2774-z
    1. Ferchak C, Meneghini L. Obesity, bariatric surgery and type 2 diabetes—a systematic review. Diabetes Metab Res Rev 2004;20:438–45. 10.1002/dmrr.507
    1. Staimez L, Weber M, Narayan K et al. . A systematic review of overweight, obesity, and type 2 diabetes among Asian American subgroups. Curr Diabetes Rev 2013;9:312–31. 10.2174/15733998113099990061
    1. Knowler W, Barrett-Connor PE, Fowler S et al. . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403. 10.1056/NEJMoa012512
    1. Buehler A, Cavalcanti A, Berwanger O et al. . Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with metaanalysis of randomized controlled trials. Cardiovasc Ther 2013;31:147–60. 10.1111/j.1755-5922.2011.00308.x
    1. Sayah FA, Williams B, Johnson J. Measuring health literacy in individuals with diabetes: a systematic review and evaluation of available measures. Health Educ Behav 2013;40:42–55. 10.1177/1090198111436341
    1. Lindstroöm J, Ilanne-Parikka P, Peltonen M et al. . Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673–9. 10.1016/S0140-6736(06)69701-8
    1. Sanz C, Gautier JF, Hanaire H. Physical exercise for the prevention and treatment of type 2 diabetes. Diabetes Metab 2010;36:346–51. 10.1016/j.diabet.2010.06.001
    1. Tabák A, Herder C, Rathmann W et al. . Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279–90. 10.1016/S0140-6736(12)60283-9
    1. Alexander G, Sehgal N, Moloney R et al. . National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med 2008;168:2088–94. 10.1001/archinte.168.19.2088
    1. Furler J, Hii J, Liew D et al. . The “cost” of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice. BMC Fam Pract 2013;14:32 10.1186/1471-2296-14-32
    1. Teoh H, Després JP, Dufour R et al. . Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing? Can J Cardiol 2013;29:960–8. 10.1016/j.cjca.2012.12.001
    1. Bodenheimer T, Lorig K, Holman H et al. . Patient self-management of chronic disease in primary care. JAMA 2002;288:2469–75. 10.1001/jama.288.19.2469
    1. Bodenheimer T, Wagner E, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288:1909–14. 10.1001/jama.288.15.1909
    1. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775–9. 10.1001/jama.288.14.1775
    1. Northern Health Authority. The group medical appointment manual. 1st edn Northern Health Authority, 2007.
    1. Trento M, Passera P, Tomalino M et al. . Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up. Diabetes Care 2001;24:995–1000. 10.2337/diacare.24.6.995
    1. Trento M, ssera P, Borgo E et al. . A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. Diabetes Care 2004;27:670–5. 10.2337/diacare.27.3.670
    1. Trento M, Gamba S, Gentile L et al. . Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 2010;33:745–7. 10.2337/dc09-2024
    1. Sicuro J, Bondonio P, Charrier L et al. . Cost analysis of group versus usual care in patients with type 2 diabetes in the ROMEO clinical trial. Nutr Metab Cardiovasc Dis 2013;23:e13–4. 10.1016/j.numecd.2012.11.005
    1. Housden L, Wong S, Dawes M. Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis. CMAJ 2013;185:E635–44. 10.1503/cmaj.130053
    1. Edelman D, McDuffie J, Oddone E et al. . Shared medical appointments for chronic medical conditions: a systematic review. VAESP Project #09-010, ed. Washington DC: Department of Veterans Affairs (US), 2012.
    1. Folstein M, Folstein S, McHugh P. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98. 10.1016/0022-3956(75)90026-6
    1. Blair S, Dunn A, Marcus B et al. . Active living every day. Windsor: Human Kinetics, 2001.
    1. Hologic Inc. Hologic QDR user's guide. Bedford, MA: Hologic Inc; 2000.
    1. Washburn R, McAuley E, Katula J et al. . The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol 1999;52:643–51. 10.1016/S0895-4356(99)00049-9
    1. Greene J, Hibbard J. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med 2011;27:520–6. 10.1007/s11606-011-1931-2
    1. Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood) 2013;32:207–14. 10.1377/hlthaff.2012.1061
    1. Mosen D, Schmittdiel J, Hibbard J et al. . Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambulatory Care Manage 2007;30:21–9. 10.1097/00004479-200701000-00005
    1. Deen D, Lu WH, Rothstein D et al. . Asking questions: the effect of a brief intervention in community health centers on patient activation. Patient Educ Couns 2011;84:257–60. 10.1016/j.pec.2010.07.026
    1. Hibbard J, Stockard J, Mahoney E et al. . Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004;39: (4 Pt 1):1005–26. 10.1111/j.1475-6773.2004.00269.x
    1. Green C, Perrin N, Polen M et al. . Development of the patient activation measure for mental health. Adm Policy Ment Health 2010;37:327–33. 10.1007/s10488-009-0239-6
    1. Chen J, Mortensen K, Bloodworth R. Exploring contextual factors and patient activation- evidence from a nationally representative sample of patients with depression. Health Educ Behav 2014;41:614–24. 10.1177/1090198114531781
    1. Dixon A, Hibbard J, Tusler M. How do people with different levels of activation. Patient 2009;2:257–68. 10.2165/11313790-000000000-00000
    1. Kukla M, Salyers M, Lysaker P. Levels of patient activation among adults with schizophrenia: associations with hope, symptoms, medication adherence, and recovery attitudes. J Nerv Ment Dis 2013;201:339–44. 10.1097/NMD.0b013e318288e253
    1. Wong S, Peterson S, Black C. Patient activation in primary healthcare. A comparison between healthier individuals and those with a chronic illness. Med Care 2011;49:469–79. 10.1097/MLR.0b013e31820bf970
    1. Donald M, Ware R, Ozolins L et al. . The role of patient activation in frequent attendance at primary care: a population-based study of people with chronic disease. Patient Educ Couns 2011;83:217–21. 10.1016/j.pec.2010.05.031
    1. Hibbard J, Gilburt H. Supporting people to manage their health. An introduction to patient activation. London, UK: The King's Fund, 2014.
    1. Hibbard JH, Mahoney E. Toward a theory of patient and consumer activation. Patient Educ Couns 2010;78:377–81. 10.1016/j.pec.2009.12.015
    1. [No authors listed]. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 1988;11:725–32. 10.2337/diacare.11.9.725
    1. Dolan P, Roberts J. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care 2002;40:442–6. 10.1097/00005650-200205000-00009
    1. Davis J, Liu-Ambrose T, Khan K et al. . SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions. Osteoporos Int 2012;23:1849–57. 10.1007/s00198-011-1770-3
    1. Davis J, Marra C, Robertson M et al. . Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int 2011;22:1355–66. 10.1007/s00198-010-1356-5
    1. Drummond M, Sculpher M, Torrance G et al. . Methods for the economic evaluation of health care programmes. 3rd edn New York: Oxford University Press, 2005.
    1. Kroenke K, Spitzer R, Williams J et al. . Anxiety disorders in primary care: prevalence, imirment, comorbidity, and detection. Ann Intern Med 2007;146:317–25. 10.7326/0003-4819-146-5-200703060-00004
    1. Hoppmann C, Coats A, Blanchard-Fields F. Goals and everyday problem solving: examining the link between age-related goals and problem-solving strategy use. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2008;15:401–23. 10.1080/13825580701533777
    1. Slade L. Time-sampling research in health psychology: potential contributions and new trends. Eur Health Psychol 2011;13:65–9.
    1. Hoppmann C, Gerstorf D. Spousal goals, affect quality, and collaborative problem solving: evidence from a time-sampling study with older couples. Res Hum Dev 2013;10:70–87. 10.1080/15427609.2013.760260
    1. Schwarzer R. Modeling health behavior change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol 2008;57:1–29. 10.1111/j.1464-0597.2007.00325.x
    1. Liu-Ambrose T, Khan K, Eng J et al. . The beneficial effects of group-based exercises on fall risk profile and physical activity persist 1year postintervention in older women with low bone mass: follow-up after withdrawal of exercise. J Am Geriatr Soc 2005;53:1767–73. 10.1111/j.1532-5415.2005.53525.x
    1. Davis J, Marra C, Beattie B et al. . Sustained cognitive and economic benefits of resistance training among community-dwelling senior women: a 1-year follow-up study of the Brain Power study. Arch Intern Med 2010;170:2036–8. 10.1001/archinternmed.2010.462
    1. Pradhan A, Rifai N, Buring J et al. . Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120:720–7. 10.1016/j.amjmed.2007.03.022
    1. Khaw K, Wareham N, Bingham S et al. . Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413–20. 10.7326/0003-4819-141-6-200409210-00006
    1. Kodama S, Horikawa C, Fujihara K et al. . Use of high-normal levels of hemoglobin A1C and fasting plasma glucose for diabetes screening and prediction—a meta-analysis. Diabetes Metab Res Rev 2013;29:680–92. 10.1002/dmrr.2445
    1. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011;34:S184–90. 10.2337/dc11-s216
    1. Edelman D, Gierisch J, McDuffie J et al. . Shared medical appointments for patients with diabetes mellitus: a systematic review. J Gen Intern Med 2015;30:99–106. 10.1007/s11606-014-2978-7
    1. Trost SG, O'Neil M. Clinical use of objective measures of physical activity. Br J Sports Med 2014;48:178–81. 10.1136/bjsports-2013-093173
    1. Lee IM, Shiroma EJ. Using accelerometers to measure physical activity in large-scale epidemiological studies: issues and challenges. Br J Sports Med 2014;48:197–201.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅